Genzyme expands its market for MS drug in Latin America
June 30, 2014 at 13:30 PM EDT
Genzyme’s drug to treat adult patients with multiple sclerosis has received approval by yet another agency outside the U...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.